Tofflon Science and Technology Group Co (300171.SZ) Osake Kurssi

Tofflon Science and Technology Group Co Kurssi

SZSE·SULJETTU
14,10
​
Markkina suljettu

Viimeisten 18 vuoden aikana Tofflon Science and Technology Group Con liikevaihto kasvoi 21,1 % vuodessa ja ylsi 5,23 Mrd. CNY:een. Osakekohtainen tulos on kasvanut 8,5 % vuodessa viimeisten 18 vuoden aikana. Tofflon Science and Technology Group Con nettomarginaali 3,8 % on laskenut verrattuna 19,7 %:iin muutama vuosi sitten. Nykyhinnalla osinkotuotto on noin 0,75 %. Jakosuhde on noin 40 % tuloksesta. Osinko on kasvanut 0,2 % vuodessa viimeisten 14 vuoden aikana. Tofflon Science and Technology Group Con 12 kuukauden konsensustavoitehinta on 18,87 CNY, noin yli kurssia 33,8 %. 6 analyytikosta 0 suosittaa ostoa — kokonaiskonsensus on Myy.

Tofflon Science and Technology Group Co osakekurssi

Hae nämä tiedot Eulerpool API:n kautta

100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia

Tofflon Science and Technology Group Co liiketoimintamalli ja osakeanalyysi

Tofflon Science and Technology Group Co Ltd on kiinalainen yritys, joka erikoistuu farmakenteellisten koneiden, laitteiden ja lisävarusteiden sekä elintarvike- ja juomakoneiden valmistukseen. Yrityksen pääkonttori sijaitsee Hangzhoussa, ja se perustettiin vuonna 2007.

Usein kysytyt kysymykset Tofflon Science and Technology Group Co -osakkeesta

Tofflon Science and Technology Group Co Ltd. is a company that specializes in the production and supply of pharmaceutical equipment and solutions. Its business model revolves around developing and manufacturing high-quality equipment for the pharmaceutical industry, including freeze-dryers, washing machines, and sterilization systems. With a focus on research and development, Tofflon Science and Technology Group aims to meet the evolving needs of the pharmaceutical sector by providing innovative and efficient solutions. By maintaining a strong presence in the market and continuously improving its products, the company strives to be a trusted partner for pharmaceutical companies worldwide.

Tofflon Science and Technology Group Co Ltd is primarily active in the pharmaceutical and biotech industries.

The main competitors of Tofflon Science and Technology Group Co Ltd in the market include companies such as Alfa Laval AB, GEA Group AG, and SPX Flow Inc. These companies also specialize in providing advanced solutions for the pharmaceutical and biotechnology industries. However, Tofflon Science and Technology Group Co Ltd maintains its competitive edge through its innovative product range, strong market presence, and commitment to quality. With its cutting-edge technologies and customer-centric approach, Tofflon Science and Technology Group Co Ltd continues to thrive in the market and position itself as a leading player in the industry.

Tofflon Science and Technology Group Co Ltd is a renowned company specializing in the development and manufacturing of advanced pharmaceutical and biotechnological equipment. Founded in [year], Tofflon Science and Technology Group has grown into a global leader in its industry. With a strong emphasis on research and development, the company has achieved remarkable progress in providing innovative solutions for the pharmaceutical and biotech sectors. Tofflon Science and Technology Group's commitment to quality and cutting-edge technologies has earned them a stellar reputation among their clients worldwide. With a rich history of delivering top-notch products and services, Tofflon Science and Technology Group continues to play a significant role in shaping the future of the pharmaceutical and biotech industries.

Tofflon Science and Technology Group Co Ltd has achieved significant milestones in its history. The company has successfully expanded its operations internationally, establishing a strong global presence. Tofflon Science and Technology Group Co Ltd has also been recognized for its innovative research and development efforts, leading to the introduction of groundbreaking products and technologies. Additionally, the company has achieved remarkable financial growth, maintaining a steady increase in its revenue and market share over the years. Tofflon Science and Technology Group Co Ltd's commitment to excellence and its continuous pursuit of technological advancements have positioned it as a leader in the industry.

Tofflon Science and Technology Group Co Ltd primarily operates in China.

Tofflon Science and Technology Group Co Ltd embodies the values of innovation, quality, and customer satisfaction. Their corporate philosophy centers around continuously improving and providing advanced technology solutions to various industries such as pharmaceuticals, biotechnology, and food processing. Tofflon Science and Technology Group Co Ltd strives to exceed customer expectations by offering cutting-edge products and services that meet international standards. With a focus on research and development, they aim to contribute to the advancement of science and technology by delivering reliable solutions that enhance efficiency and productivity. The commitment to excellence and customer-centric approach makes Tofflon Science and Technology Group Co Ltd a leading player in the industry.

Analyytikot asettavat tällä hetkellä Tofflon Science and Technology Group Co-osakkeelle keskimääräisen tavoitehinnan 18,87 CNY (mediaani: 18,87 CNY), mikä merkitsee +33,8 % viimeisimpään hintaan verrattuna. Konsensus perustuu 6 analyytikkoarvioon.

6 analyytikkoa arvioi tällä hetkellä Tofflon Science and Technology Group Co-osaketta: 0 suosittaa ostoa, 3 pitoa ja 3 myyntiä. Vuodelle 2026 analyytikot odottavat Tofflon Science and Technology Group Co-yhtiöltä 5,54 Mrd. CNY liikevaihtoa ja 0,39 CNY osakekohtaista tulosta.

Nykyisellä valuuttakurssilla Tofflon Science and Technology Group Co-osake noteerataan hintaan 1,89 EUR (14,10 CNY).

Tofflon Science and Technology Group Co-osake (300171.SZ) on listattuna 1 pörssissä, muun muassa: Shenzhen (300171.SZ).

Tofflon Science and Technology Group Co Ltd is a leading company in the field of pharmaceutical processing technology and is headquartered in China. Since its founding in 1993, the company has been at the forefront of pharmaceutical processing and offers a wide range of products and services. The company Tofflon Science and Technology Group Co Ltd is divided into two main areas: the development and manufacturing unit and the service unit. The development and manufacturing unit is involved in the development and manufacture of pharmaceutical processing machines, including filling machines, sealing machines, cleaning and sterilization equipment, and lyophilizers. The company focuses on the automated production of medicines and biopharmaceuticals, and offers a wide range of technical solutions for the pharmaceutical industry. The service unit of Tofflon Science and Technology Group Co Ltd offers a variety of services, including consulting, engineering, training, maintenance, and spare parts. The focus is on supporting customers in the development and implementation of production processes to create efficient, fast, and cost-effective solutions. Continuous innovation and improvement are at the core of Tofflon Science and Technology Group Co Ltd. The company continuously invests in research and development to improve and advance medication manufacturing technology. This allows Tofflon Science and Technology Group Co Ltd to offer innovative solutions that support customers in the efficient implementation of production processes. In the pharmaceutical industry, the processing of medications in a sterile environment is of crucial importance. Tofflon Science and Technology Group Co Ltd is aware of this and has developed a range of solutions that ensure compliance with the industry's strict requirements. The products and services offered by Tofflon Science and Technology Group Co Ltd include: - Filling machines: The company offers a wide range of filling machines that enable fast and efficient filling of liquids, pastes, and powders. - Sealing machines: Tofflon Science and Technology Group Co Ltd offers automated sealing machines for quick and efficient encapsulation of drugs to ensure the integrity and quality of the medications. - Cleaning and sterilization equipment: The cleaning and sterilization equipment from Tofflon Science and Technology Group Co Ltd is tailored to the needs of the pharmaceutical industry and ensures safe and effective cleaning and sterilization of equipment. - Lyophilizer: Tofflon Science and Technology Group Co Ltd offers a wide range of lyophilizers that enable effective and safe drying of medications and biopharmaceuticals. Overall, the company Tofflon Science and Technology Group Co Ltd demonstrates a strong focus on innovation and a strong presence in pharmaceutical processing technology. By providing efficient solutions and services, the company is able to meet the needs of customers and support them in the implementation of production processes.

odotettu liikevaihto Tofflon Science and Technology Group Co on 5,54 Mrd. CNY. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.

odotettu voitto Tofflon Science and Technology Group Co on 294,87 M CNY. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.

Tofflon Science and Technology Group Co:n hinta-voitto-suhde (P/E) on tällä hetkellä 36,38. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Tofflon Science and Technology Group Co-osakkeen arvostusta.

Tofflon Science and Technology Group Co:n hinta-myynti-suhde (P/S) on tällä hetkellä 1,94. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Tofflon Science and Technology Group Co-osakkeen arvostuskennuslukuna.

Tofflon Science and Technology Group Co:n Eulpool-laatuscore on 3/10.

Tofflon Science and Technology Group Co:n ISIN on CNE100000ZP0. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

Tofflon Science and Technology Group Co:n ticker on 300171.SZ. Tämä pörssinoteeraus käytetään Tofflon Science and Technology Group Co-osakkeiden kauppaan pörssissä.

Käypä arvoTerminal
11,84 CNY
Yliarviointia/AliarviointiaTerminal
Reilusti arvostettu
Toimiala
Terveydenhuollon laitteet ja tarvikkeet
Osakkeiden lukumäärä
Työntekijät
Liikevaihto per työntekijä
1,43 M CNY
Liikevaihdon kasvu Ø 5 vuotta
EBIT-kasvu Ø 5 vuotta
Nettotulon kasvu Ø 5 vuotta
Verkkosivusto tofflon.com
Valuutta
CNY
Julkinen listaus
1.2.2011
ISIN
CNE100000ZP0
CUSIP
Y76894107
SEDOL
B42MVJ7
Markkina-arvo
52 viikon vaihteluväli
PEG-suhde
1,94
P/E-suhde
P/Ee-suhde 2026
35,70
P/Ee-suhde 2027
22,56
P/Ee-suhde 2028
17,20
P/S-suhde
P/Se-suhde
1,94
EV/EBIT
23,00
P/B-suhde
1,33
ROE (oman pääoman tuotto)
ROA (varojen tuotto)
ROCE (pääomakäytön tuotto)
ROIC (sijoitetun pääoman tuotto)
2,50 %
Osinko
Osinkotuotto
0,75 %
Arvioitu osinkotuotto
1,04 %
Jakosuhde
40,25 %
Osinkojen kasvu Ø5V
−17,66 %
Osingonmaksut vuodessa
2
Osinkoa maksettu siitä
15 vuotta
Osinkoa ei alennettu siitä
0 vuotta
Osinkoa nostettu siitä
0 vuotta
Lähdevero
10,00 %
Viimeksi päivitetty 31.10.2026 klo 15.45

Tofflon Science and Technology Group Co vertaisryhmä

Tofflon Science and Technology Group Co Ticker

SHZ · 300171.SZ

Tofflon Science and Technology Group Co FIGI

300171:CH · BBG0019J0CM5300171:CS · BBG0019PG3Q0300171:C2 · BBG00F13BGY3

Kaikki tunnusluvut ja syvällinen analyysi Tofflon Science and Technology Group Co:sta

Meidän osakeanalyysimme Tofflon Science and Technology Group Co-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Tofflon Science and Technology Group Co:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: